The aggregation of the aberrant, insoluble form of α-synuclein significantly influences PD progression, This may entail the presence of misfolded α-synuclein within pathogen-associated molecular patterns or damage-associated molecular patterns [10]. This evidence concerns the gene SNCA and Parkinson disease.